Fujifilm Holdings Corp. will restart a clinical trial in Japan of the company’s antiviral drug Avigan for the treatment of Covid-19, the Nikkei newspaper reported on Feb. 21.

Japan’s Covid-19 cases reached a new daily record on Jan. 6, as the government faced mounting pressure from health experts to impose a strict state of emergency for the Tokyo greater metropolitan area.